Gabapentin in Phantom and Stump Pain

• Status: Completed
• Trial end date: 2006-06-01
• Target enrollment: 0
• Participant gender: All

Summary

To investigate whether gabapentin can prevent phantom and stump pain after amputation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Danish Pain Research Center
• Collaborator: Pfizer
• Treatments: Gabapentin; gamma-Aminobutyric Acid

Criteria

Inclusion Criteria:

1. Amputation of crus or femur

Exclusion Criteria:

1. Patients who cannot cooperate

2. Fertile women without sufficient contraceptives

3. Allergy to gabapentin

4. Earlier amputation of the same limb except toes

5. Serious lever, kidney, cardiac, respiratory, haematological disease.-